KMT2C is a potential biomarker of prognosis and chemotherapy sensitivity in breast cancer
Xinhua Liu, Rongfang Qiu, Min Xu, Miaomiao Meng, Siyu Zhao, Jiansong Ji, Yang Yang
Topics & Concepts
Breast cancerCarcinogenesisEpigeneticsCancer researchBiologyCancerBiomarkerOncologyMedicineGeneGeneticsEpigenetics and DNA MethylationMicroRNA in disease regulationHistone Deacetylase Inhibitors Research